Biohit Oyj Press release, September 3, 2018 at 10.00 p.m. local time (EET)
Biohit Oyj and Retail partner ApS have signed an agreement for the distribution of the smoking cessation product Acetium lozenge in Danmark and Sweden.
The new Acetium lozenge is an effective and safe product that helps quit smoking without nicotine and it has no side effects. Acetium lozenge eliminates cigarette smoke-derived carcinogenic acetaldehyde in the saliva during smoking. According to the clinical trial, Acetium lozenge helps to quit smoking (1-3).
CEO Frode Telstad, Retail partner ApS:”We at Retail Partner are proud to be chosen as BIOHIT’s future partner and distributor in Denmark and Sweden. As a distributor, already focusing on personal and health care categories, we believe we have found a perfect fit to our existing portfolio. Over the last many years Scandinavians have been able to reduce smoking to a lower level, and with the launch of Acetium we are committed in helping this development to continue also in the years to come.”
CEO Semi Korpela, Biohit Oyj:”With this agreement Retail Partner ApS S.A. obtains the rights to distribute Acetium lozenge in Danmark and Sweden. Acetium lozenge offers a side effect-free and safe option to abandon this unhealthy addiction. Smoking-related diseases represent a major health burden in Western countries.”
Additional information:
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com
1. Syrjänen K et al. Slow-release L-cysteine (Acetium®) lozenge is an effective new method in smoking cessation. A randomized, double-blind, placebo-controlled intervention. Anticancer Res 2017;37:3639-3648.
2. https://newsclient.omxgroup.com/cdsPublic/viewDisclosure.action?disclosureId=785626&lang=en
3. http://www.biohithealthcare.com/products/acetaldehyde-binding-products/products/25/acetium-lozenge
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com
Retail Partner ApS in brief
Retail Partner ApS is a Nordic distributor company established in Copenhagen, Denmark. Our ambition is to set up long-term partnerships with branded